Apyx Medical (APYX) has received 510(k) clearance from the FDA for the AYON Body Contouring System. The company said it is actively preparing for a commercial launch of AYON with key surgeons in critical geographies starting in the second half of 2025.
The company said this initial 510(k) clearance for AYON covers a wide variety of aesthetic treatments, including Renuvion to address loose and lax skin, ultrasound-assisted liposuction, electrocoagulation to support procedures requiring removal of excess tissue, along with several others. The company plans to expand the cleared indications for AYON, to include power liposuction, with an additional 510(k) submission later in the current year.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.